Aragen Bioscience, Inc. Successfully Completes Antibody Humanization Project
MORGAN HILL, Calif.--(BUSINESS WIRE)--Aragen Bioscience Inc. and XOMA Corporation recently announced that they had joined forces to offer XOMA’s antibody humanization technology, Human Engineering™, through Aragen Bioscience’s contract services. The first such project has just completed meeting all affinity specifications within a very tight time frame.